Cargando…
MicroRNAs as Candidate Biomarkers for Alzheimer’s Disease
The neurological damage of Alzheimer’s disease (AD) is thought to be irreversible upon onset of dementia-like symptoms, as it takes years to decades for occult pathologic changes to become symptomatic. It is thus necessary to identify individuals at risk for the development of the disease before sym...
Autores principales: | Kanach, Colin, Blusztajn, Jan K., Fischer, Andre, Delalle, Ivana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930943/ https://www.ncbi.nlm.nih.gov/pubmed/33535543 http://dx.doi.org/10.3390/ncrna7010008 |
Ejemplares similares
-
MicroRNAs as biomarkers for CNS disease
por: Rao, Pooja, et al.
Publicado: (2013) -
MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease
por: Raffaele, Ivana, et al.
Publicado: (2023) -
The Expression of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) in Hippocampal
Arterioles Declines During Progression of Alzheimer’s Disease
por: Anderson, Kelley E, et al.
Publicado: (2020) -
Cytokines and MicroRNAs as Candidate Biomarkers for Systemic Lupus Erythematosus
por: Stypińska, Barbara, et al.
Publicado: (2015) -
microRNAs as Early Biomarkers of Alzheimer’s Disease: A Synaptic Perspective
por: Siedlecki-Wullich, Dolores, et al.
Publicado: (2021)